Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
5.84
-0.62 (-9.60%)
Apr 29, 2026, 3:04 PM CST
SHE:002198 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 30.48 | 20.61 | 34.32 | 43.93 | 1.48 | Upgrade
|
| Depreciation & Amortization | 21.29 | 19.55 | 24.21 | 25.89 | 28.4 | Upgrade
|
| Other Amortization | 2.06 | 0.16 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.13 | -1.61 | -0.14 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.81 | 0.26 | 0.05 | 2.58 | 0.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.51 | -0.68 | -1.11 | -0.67 | 27.68 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 4.05 | -0.65 | 2.66 | -2 | Upgrade
|
| Other Operating Activities | -0.1 | 1.18 | 0.78 | 1.11 | 0.84 | Upgrade
|
| Change in Accounts Receivable | -111.58 | 32.22 | 118.37 | -86.45 | 9.62 | Upgrade
|
| Change in Inventory | 6.72 | 0.36 | -2.36 | -8.41 | -0.78 | Upgrade
|
| Change in Accounts Payable | 55.46 | -14.33 | -75.13 | 44.11 | -14.65 | Upgrade
|
| Operating Cash Flow | 9 | 60.85 | 98.45 | 27.15 | 51.8 | Upgrade
|
| Operating Cash Flow Growth | -85.21% | -38.20% | 262.57% | -47.58% | -46.53% | Upgrade
|
| Capital Expenditures | -109.92 | -38.7 | -5.06 | -2.74 | -2.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.89 | 1.45 | 0.09 | 0.01 | Upgrade
|
| Investment in Securities | -32.38 | - | - | - | 32.5 | Upgrade
|
| Other Investing Activities | 2.15 | 205 | -146.63 | -48.38 | 25.04 | Upgrade
|
| Investing Cash Flow | -140.14 | 167.18 | -150.24 | -51.03 | 55.21 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 31.11 | Upgrade
|
| Total Debt Issued | - | - | - | - | 31.11 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -15 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -31.11 | - | Upgrade
|
| Total Debt Repaid | - | - | - | -31.11 | -15 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -31.11 | 16.11 | Upgrade
|
| Common Dividends Paid | - | -25.4 | - | - | - | Upgrade
|
| Other Financing Activities | -38.25 | - | -0 | -0.45 | -1.02 | Upgrade
|
| Financing Cash Flow | -38.25 | -25.4 | -0 | -31.56 | 15.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.48 | - | - | - | - | Upgrade
|
| Net Cash Flow | -170.87 | 202.63 | -51.79 | -55.44 | 122.1 | Upgrade
|
| Free Cash Flow | -100.92 | 22.14 | 93.39 | 24.41 | 49.46 | Upgrade
|
| Free Cash Flow Growth | - | -76.29% | 282.53% | -50.63% | -41.95% | Upgrade
|
| Free Cash Flow Margin | -26.30% | 5.89% | 17.51% | 3.70% | 8.61% | Upgrade
|
| Free Cash Flow Per Share | -0.20 | 0.04 | 0.18 | 0.05 | 0.10 | Upgrade
|
| Cash Interest Paid | - | 0 | 0 | 0.45 | 1.02 | Upgrade
|
| Cash Income Tax Paid | 47.22 | 45.55 | 72.08 | 73.23 | 75.35 | Upgrade
|
| Levered Free Cash Flow | -115.78 | 16.77 | 84.77 | 5.75 | 73.89 | Upgrade
|
| Unlevered Free Cash Flow | -115.78 | 16.78 | 84.77 | 6.04 | 74.53 | Upgrade
|
| Change in Working Capital | -50.18 | 17.33 | 40.99 | -48.37 | -4.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.